
    
      The study will include Patients undergoing IVF treatment with controlled ovarian
      hyperstimulation using a daily GnRH analog in a long protocol,older then 18, .The women will
      be randomised to two groups.Both groups will be given vaginal tabs of natural micronized
      progesterone(Uterogestan)

      The study group will be given oral estradiol Valerate 4 mg.Prior to treatment, each patient
      will be signed on informed concent.

      Patients will be excluded if they are older than 40, have any systemic illnesses or a
      personal or family history of a thromboembolic event.

      Follow up:

      Verification of pregnancy status and hormonal profile will be carried out on day fourteen
      after embryo transfer by means of serum hCG,P and E2. clinical pregnancy will be defined as
      the presence of a gestational sac on ultrasonography on day 21 after embryo transfer and
      fetal heart will be evaluated on day 28
    
  